RNA Oligonucleotide Synthesis Service - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2759462
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 151
-
According to latest Research, the global market for RNA Oligonucleotide Synthesis Service should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China RNA Oligonucleotide Synthesis Service market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States RNA Oligonucleotide Synthesis Service market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Commercial grew percent to account for percent of the total market sales, and Academic Research grew percent.
This report studies and analyses global RNA Oligonucleotide Synthesis Service status and future trends, to help determine the RNA Oligonucleotide Synthesis Service market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for RNA Oligonucleotide Synthesis Service, and provides market size (US$ million) and Year-over-Year growth, considering 2023 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global RNA Oligonucleotide Synthesis Service market size, history data 2019-2024, and forecast data 2024-2029, (US$ million)
(2) Global RNA Oligonucleotide Synthesis Service by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(3) China RNA Oligonucleotide Synthesis Service by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(4) Global RNA Oligonucleotide Synthesis Service key consuming regions, consumption value and demand structure
(5) RNA Oligonucleotide Synthesis Service industry chains, upstream, midstream and downstream
Market segment by players, this report covers
GenScript
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Creative Biolabs
Bio Basic
Kaneka Eurogentec SA
AltaBioscience
Synbio Technologies
TriLink
Azenta Life Science
KareBay Biochem
Creative Biogene
Generi Biotech
Primetech
General Biosystems
Market segment by Type, covers
Standard Oligonucleotides
Micro-Oligonucleotides
Large-scale Oligonucleotides
Degenerate Primers
Long Oligos Synthesis
Market segment by Application, can be divided into
Commercial
Academic Research
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe RNA Oligonucleotide Synthesis Service product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global RNA Oligonucleotide Synthesis Service market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 3: China RNA Oligonucleotide Synthesis Service market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 4: RNA Oligonucleotide Synthesis Service industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide RNA Oligonucleotide Synthesis Service Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 RNA Oligonucleotide Synthesis Service Definition
1.2 Global RNA Oligonucleotide Synthesis Service Market Size and Forecast
1.3 China RNA Oligonucleotide Synthesis Service Market Size and Forecast
1.4 China Percentage in Global Market
1.5 RNA Oligonucleotide Synthesis Service Market Size: China VS Global Growth Rate, 2019-2030
1.6 RNA Oligonucleotide Synthesis Service Market Dynamics
1.6.1 RNA Oligonucleotide Synthesis Service Market Drivers
1.6.2 RNA Oligonucleotide Synthesis Service Market Restraints
1.6.3 RNA Oligonucleotide Synthesis Service Industry Trends
1.6.4 RNA Oligonucleotide Synthesis Service Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of RNA Oligonucleotide Synthesis Service, Global Market Share by Company, 2019-2024
2.2 Global RNA Oligonucleotide Synthesis Service Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global RNA Oligonucleotide Synthesis Service Concentration Ratio
2.4 Global RNA Oligonucleotide Synthesis Service Mergers & Acquisitions, Expansion Plans
2.5 Global RNA Oligonucleotide Synthesis Service Major Companies Product Type
2.6 Head Office and RNA Oligonucleotide Synthesis Service Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of RNA Oligonucleotide Synthesis Service, China Market Share by Company, 2019-2024
3.2 China RNA Oligonucleotide Synthesis Service Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 RNA Oligonucleotide Synthesis Service Industry Chain
4.2 RNA Oligonucleotide Synthesis Service Upstream Analysis
4.2.1 RNA Oligonucleotide Synthesis Service Core Raw Materials
4.2.2 Main Manufacturers of RNA Oligonucleotide Synthesis Service Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 RNA Oligonucleotide Synthesis Service Production Mode
4.6 RNA Oligonucleotide Synthesis Service Procurement Model
4.7 RNA Oligonucleotide Synthesis Service Industry Sales Model and Sales Channels
4.7.1 RNA Oligonucleotide Synthesis Service Sales Model
4.7.2 RNA Oligonucleotide Synthesis Service Typical Distributors
5 Sights by Type5.1 RNA Oligonucleotide Synthesis Service Classification
5.1.1 Standard Oligonucleotides
5.1.2 Micro-Oligonucleotides
5.1.3 Large-scale Oligonucleotides
5.1.4 Degenerate Primers
5.1.5 Long Oligos Synthesis5.2 By Type, Global RNA Oligonucleotide Synthesis Service Consumption Value & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global RNA Oligonucleotide Synthesis Service Consumption Value, 2019-2030
6 Sights by Application6.1 RNA Oligonucleotide Synthesis Service Segment by Application
6.1.1 Commercial
6.1.2 Academic Research6.2 By Application, Global RNA Oligonucleotide Synthesis Service Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global RNA Oligonucleotide Synthesis Service Consumption Value, 2019-2030
7 Sales Sights by Region7.1 By Region, Global RNA Oligonucleotide Synthesis Service Consumption Value, 2019 VS 2024 VS 2030
7.2 By Region, Global RNA Oligonucleotide Synthesis Service Consumption Value, 2019-2030
7.3 North America
7.3.1 North America RNA Oligonucleotide Synthesis Service & Forecasts, 2019-2030
7.3.2 By Country, North America RNA Oligonucleotide Synthesis Service Market Size Market Share7.4 Europe
7.4.1 Europe RNA Oligonucleotide Synthesis Service Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe RNA Oligonucleotide Synthesis Service Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific RNA Oligonucleotide Synthesis Service Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific RNA Oligonucleotide Synthesis Service Market Size Market Share7.6 South America
7.6.1 South America RNA Oligonucleotide Synthesis Service Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America RNA Oligonucleotide Synthesis Service Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global RNA Oligonucleotide Synthesis Service Market Size & CAGR, 2019 VS 2024 VS 2030
8.2 By Country, Global RNA Oligonucleotide Synthesis Service Consumption Value, 2019-2030
8.3 U.S.
8.3.1 U.S. RNA Oligonucleotide Synthesis Service Market Size, 2019-2030
8.3.2 By Type, U.S. RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.3.3 By Application, U.S. RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 20308.4 Europe
8.4.1 Europe RNA Oligonucleotide Synthesis Service Market Size, 2019-2030
8.4.2 By Type, Europe RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.4.3 By Application, Europe RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 20308.5 China
8.5.1 China RNA Oligonucleotide Synthesis Service Market Size, 2019-2030
8.5.2 By Type, China RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.5.3 By Application, China RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 20308.6 Japan
8.6.1 Japan RNA Oligonucleotide Synthesis Service Market Size, 2019-2030
8.6.2 By Type, Japan RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.6.3 By Application, Japan RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.7 South Korea
8.7.1 South Korea RNA Oligonucleotide Synthesis Service Market Size, 2019-2030
8.7.2 By Type, South Korea RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.7.3 By Application, South Korea RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia RNA Oligonucleotide Synthesis Service Market Size, 2019-2030
8.8.2 By Type, Southeast Asia RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.8.3 By Application, Southeast Asia RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.9 India
8.9.1 India RNA Oligonucleotide Synthesis Service Market Size, 2019-2030
8.9.2 By Type, India RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.9.3 By Application, India RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 20308.10 Middle East & Africa
8.10.1 Middle East & Africa RNA Oligonucleotide Synthesis Service Market Size, 2019-2030
8.10.2 By Type, Middle East & Africa RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
8.10.3 By Application, Middle East & Africa RNA Oligonucleotide Synthesis Service Consumption Value Market Share, 2024 VS 2030
9 Company Profile9.1 GenScript
9.1.1 GenScript Company Information, Head Office, Market Area and Industry Position
9.1.2 GenScript Company Profile and Main Business
9.1.3 GenScript RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.1.4 GenScript RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.1.5 GenScript Recent Developments9.2 OriGene
9.2.1 OriGene Company Information, Head Office, Market Area and Industry Position
9.2.2 OriGene Company Profile and Main Business
9.2.3 OriGene RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.2.4 OriGene RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.2.5 OriGene Recent Developments9.3 BBI
9.3.1 BBI Company Information, Head Office, Market Area and Industry Position
9.3.2 BBI Company Profile and Main Business
9.3.3 BBI RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.3.4 BBI RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.3.5 BBI Recent Developments9.4 Genewiz
9.4.1 Genewiz Company Information, Head Office, Market Area and Industry Position
9.4.2 Genewiz Company Profile and Main Business
9.4.3 Genewiz RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.4.4 Genewiz RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.4.5 Genewiz Recent Developments9.5 Eurofins Genomics
9.5.1 Eurofins Genomics Company Information, Head Office, Market Area and Industry Position
9.5.2 Eurofins Genomics Company Profile and Main Business
9.5.3 Eurofins Genomics RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.5.4 Eurofins Genomics RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.5.5 Eurofins Genomics Recent Developments9.6 Gene Oracle
9.6.1 Gene Oracle Company Information, Head Office, Market Area and Industry Position
9.6.2 Gene Oracle Company Profile and Main Business
9.6.3 Gene Oracle RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.6.4 Gene Oracle RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.6.5 Gene Oracle Recent Developments
9.7 SBS Genetech
9.7.1 SBS Genetech Company Information, Head Office, Market Area and Industry Position
9.7.2 SBS Genetech Company Profile and Main Business
9.7.3 SBS Genetech RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.7.4 SBS Genetech RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.7.5 SBS Genetech Recent Developments
9.8 Creative Biolabs
9.8.1 Creative Biolabs Company Information, Head Office, Market Area and Industry Position
9.8.2 Creative Biolabs Company Profile and Main Business
9.8.3 Creative Biolabs RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.8.4 Creative Biolabs RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.8.5 Creative Biolabs Recent Developments
9.9 Bio Basic
9.9.1 Bio Basic Company Information, Head Office, Market Area and Industry Position
9.9.2 Bio Basic Company Profile and Main Business
9.9.3 Bio Basic RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.9.4 Bio Basic RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.9.5 Bio Basic Recent Developments9.10 Kaneka Eurogentec SA
9.10.1 Kaneka Eurogentec SA Company Information, Head Office, Market Area and Industry Position
9.10.2 Kaneka Eurogentec SA Company Profile and Main Business
9.10.3 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.10.4 Kaneka Eurogentec SA RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.10.5 Kaneka Eurogentec SA Recent Developments
9.11 AltaBioscience
9.11.1 AltaBioscience Company Information, Head Office, Market Area and Industry Position
9.11.2 AltaBioscience Company Profile and Main Business
9.11.3 AltaBioscience RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.11.4 AltaBioscience RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.11.5 AltaBioscience Recent Developments
9.12 Synbio Technologies
9.12.1 Synbio Technologies Company Information, Head Office, Market Area and Industry Position
9.12.2 Synbio Technologies Company Profile and Main Business
9.12.3 Synbio Technologies RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.12.4 Synbio Technologies RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.12.5 Synbio Technologies Recent Developments
9.13 TriLink
9.13.1 TriLink Company Information, Head Office, Market Area and Industry Position
9.13.2 TriLink Company Profile and Main Business
9.13.3 TriLink RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.13.4 TriLink RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.13.5 TriLink Recent Developments
9.14 Azenta Life Science
9.14.1 Azenta Life Science Company Information, Head Office, Market Area and Industry Position
9.14.2 Azenta Life Science Company Profile and Main Business
9.14.3 Azenta Life Science RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.14.4 Azenta Life Science RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.14.5 Azenta Life Science Recent Developments
9.15 KareBay Biochem
9.15.1 KareBay Biochem Company Information, Head Office, Market Area and Industry Position
9.15.2 KareBay Biochem Company Profile and Main Business
9.15.3 KareBay Biochem RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.15.4 KareBay Biochem RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.15.5 KareBay Biochem Recent Developments
9.16 Creative Biogene
9.16.1 Creative Biogene Company Information, Head Office, Market Area and Industry Position
9.16.2 Creative Biogene Company Profile and Main Business
9.16.3 Creative Biogene RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.16.4 Creative Biogene RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.16.5 Creative Biogene Recent Developments
9.17 Generi Biotech
9.17.1 Generi Biotech Company Information, Head Office, Market Area and Industry Position
9.17.2 Generi Biotech Company Profile and Main Business
9.17.3 Generi Biotech RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.17.4 Generi Biotech RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.17.5 Generi Biotech Recent Developments
9.18 Primetech
9.18.1 Primetech Company Information, Head Office, Market Area and Industry Position
9.18.2 Primetech Company Profile and Main Business
9.18.3 Primetech RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.18.4 Primetech RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.18.5 Primetech Recent Developments
9.19 General Biosystems
9.19.1 General Biosystems Company Information, Head Office, Market Area and Industry Position
9.19.2 General Biosystems Company Profile and Main Business
9.19.3 General Biosystems RNA Oligonucleotide Synthesis Service Models, Specifications and Application
9.19.4 General Biosystems RNA Oligonucleotide Synthesis Service Revenue and Gross Margin, 2019-2024
9.19.5 General Biosystems Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The RNA Oligonucleotide Synthesis Service Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the RNA Oligonucleotide Synthesis Service Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
During the projected year from 2024 to 2029, the RNA Oligonucleotide Synthesis Service Global and China Top Players Market is expected to grow at a CAGR of xx%.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the RNA Oligonucleotide Synthesis Service Global and China Top Players Market as well as its distribution among its players
The latest version of the RNA Oligonucleotide Synthesis Service Global and China Top Players Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
